Myriad Genetics

-$0.65 (-2.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MYGN and other stocks, options, and ETFs commission-free!

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments.

CEO
Paul J. Diaz
Employees
2,700
Headquarters
Salt Lake City, Utah
Founded
1991

MYGN Key Statistics

Market Cap
1.98B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
560.59K
High Today
$27.75
Low Today
$26.20
Open Price
$27.70
Volume
514.00K
52 Week High
$33.97
52 Week Low
$10.54

MYGN News

BenzingaMay 3

Recap: Myriad Genetics Q3 Earnings

Shares of Myriad Genetics (NASDAQ:MYGN) remained flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose
BenzingaApr 30

Myriad Genetics's Earnings Outlook

Myriad Genetics (NASDAQ:MYGN) unveils its next round of earnings this Monday, May 03. Here is Benzinga's everything-that-matters guide for the earnings announce

MYGN Earnings

-$0.47
-$0.21
$0.06
$0.32
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
-$0.14 per share
Actual
-$0.06 per share

You May Also Like

REGL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure